Drugs with Coverage Limitations and New Drug Review
Please Note:
- Date Review Completed and Conclusion columns are blank for those products currently undergoing review. Details will be updated as efficiently as possible following initial review.
- Conclusions are based upon decisions made at the time reviews are completed; historical information is not updated. Product management is subject to change based on new clinical evidence, provider/public feedback, advisory committee recommendations, financial considerations, etc.
- This contains approximately one year of New Drug details.
- Advisory Meeting Month is the month this recommendation will be presented at the quarterly Drug Prior Authorization Committee (DPAC) and Drug Utilization Review (DUR) Board meetings. For meeting dates, please see the MO HealthNet Calendar of Events. Certain agents may also be discussed at the quarterly Rare Disease Advisory Council meeting immediately prior to their presentation at their designated DPAC/DUR meeting.
For more information on this process please view the New Drug Review Process or contact the MO HealthNet Pharmacy Program at MHD.PharmacyAdmin@dss.mo.gov or call 573-751-6963.
| Trade Name | Generic Name | Date Review Began | Date Review Completed | Conclusion | Advisory Committee Month |
|---|---|---|---|---|---|
| SOGROYA 15 MG/1.5 ML PEN | SOMAPACITAN-BECO | 05/16/2023 | 06/27/2023 | PDL Product | July 2023 |
| UZEDY ER 100 MG/0.28 ML SYRING | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| SOGROYA 10 MG/1.5 ML PEN | SOMAPACITAN-BECO | 05/16/2023 | 06/27/2023 | PDL Product | July 2023 |
| VOWST CAPSULE | FECAL MICROBIO SPORE,LIVE-BRPK | 05/08/2023 | 06/20/2023 | Fiscal Edit | October 2023 |
| ABILIFY ASIMTUFII 960 MG/3.2ML | ARIPIPRAZOLE | 05/08/2023 | 06/20/2023 | Resource List | October 2023 |
| ABILIFY ASIMTUFII 720 MG/2.4ML | ARIPIPRAZOLE | 05/08/2023 | 06/20/2023 | Resource List | October 2023 |
| GRALISE ER 750 MG TABLET | GABAPENTIN | 05/01/2023 | 06/13/2023 | PDL Product | October 2023 |
| GRALISE ER 450 MG TABLET | GABAPENTIN | 05/01/2023 | 06/13/2023 | PDL Product | October 2023 |
| LUPRON DEPOT-PED 45 MG 6MO KIT | LEUPROLIDE ACETATE | 05/01/2023 | 06/13/2023 | PDL Product | July 2023 |
| TRIKAFTA 100-50-75 MG/75MG PKT | ELEXACAFTOR/TEZACAFTOR/IVACAFT | 05/01/2023 | 06/13/2023 | Clinical Edit | October 2023 |
| TRIKAFTA 80-40-60MG/59.5MG PKT | ELEXACAFTOR/TEZACAFTOR/IVACAFT | 05/01/2023 | 06/13/2023 | Clinical Edit | October 2023 |
| TUXARIN ER 8-54.3 MG TABLET | CHLORPHENIRAMINE/CODEINE PHOS | 05/01/2023 | 06/13/2023 | Clinical Edit | October 2023 |
| GRALISE ER 900 MG TABLET | GABAPENTIN | 05/01/2023 | 06/13/2023 | PDL Product | October 2023 |
| QALSODY 100 MG/15 ML VIAL | TOFERSEN | 05/01/2023 | 06/13/2023 | Open Access | October 2023 |
| AUSTEDO XR 24 MG TABLET | DEUTETRABENAZINE | 04/25/2023 | 06/06/2023 | PDL Product | October 2023 |